The potential impact of bisphosphonates on major adverse cardiovascular events: a study of 1,097,406 patients

Back

ESC Professional Premium Access

The potential impact of bisphosphonates on major adverse cardiovascular events: a study of 1,097,406 patients

Session: Integrating insights: from biomarkers to therapeutics in the management of acute coronary syndromes

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor K. Atieh (Dallas, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Khaled Atieh

Baylor University Medical Center, Dallas (United States of America)

0 follower

7 more presentations in this session

Increased circulating levels of standardized inflammatory and endothelial dysfunction biomarkers in patients with myocardial infarction with nonobstructive coronary arteries.

Speaker: Doctor M. Espinosa Pascual (Madrid, ES)

Markers of coagulation and early coronary stent thrombosis

Speaker: Doctor L. Galli (Vienna, AT)

The sooner the better? What is the optimal timing for coronary angiography in high-risk non-ST-elevation acute coronary syndrome

Speaker: Doctor C. Carvalho (Vila Real, PT)

Cangrelor use in ticagrelor-loaded ST-elevation myocardial infarction patients with high residual platelet reactivity: a randomized controlled trial.

Speaker: Doctor A. Lemaitre (Caen, FR)

Mortality effects of beta-blockers on myocardial infarction in patients without reduced ejection fraction or heart failure in the contemporary reperfusion era : a systematic review and meta-analysis

Speaker: Doctor P. Lee (Bronx, US)

Access the full session

Integrating insights: from biomarkers to therapeutics in the management of acute coronary syndromes

Speakers: Doctor K. Atieh, Doctor M. Espinosa Pascual, Doctor L. Galli, Doctor C. Carvalho, Doctor A. Lemaitre...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources